Chemoinformaics analysis of 8-Methoxy-3-methylnaphthalen-1-ol
| Molecular Weight | 188.226 | nRot | 1 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 19 |
| Exact Molecular Weight | 188.084 | nRing | 2 |
| Solubility: LogS | -2.604 | nHRing | 0 |
| Solubility: LogP | 1.486 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 11 |
| nHA | 2 | APOL | 29.6455 |
| nHD | 1 | BPOL | 13.7745 |
| QED | 0.467 |
| Synth | 5.983 |
| Natural Product Likeliness | 3.218 |
| NR-PPAR-gamma | 0.685 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.054 |
| Pgp-sub | 0 |
| HIA | 0.157 |
| CACO-2 | -4.77 |
| MDCK | 0.0000173 |
| BBB | 0.923 |
| PPB | 0.609242 |
| VDSS | 1.761 |
| FU | 0.389174 |
| CYP1A2-inh | 0.039 |
| CYP1A2-sub | 0.483 |
| CYP2c19-inh | 0.141 |
| CYP2c19-sub | 0.884 |
| CYP2c9-inh | 0.142 |
| CYP2c9-sub | 0.029 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.128 |
| CYP3a4-inh | 0.769 |
| CYP3a4-sub | 0.724 |
| CL | 4.695 |
| T12 | 0.248 |
| hERG | 0.003 |
| Ames | 0.015 |
| ROA | 0.884 |
| SkinSen | 0.095 |
| Carcinogencity | 0.56 |
| EI | 0.017 |
| Respiratory | 0.702 |
| NR-Aromatase | 0.865 |
| Antiviral | No |
| Prediction | 0.668367 |